content top

Half-fluence PDT for Chronic CSCR

Purpose: To evaluate the prognostic factors and effect of half-fluence photodynamic therapy (PDT) in the treatment of chronic central serous chorioretinopathy (CSC). Methods: We retrospectively reviewed fifty-six eyes of 56 patients with chronic CSC who underwent half-fluence PDT. Postoperative evaluation included improvements in visual acuity, changes in central macular thickness with the optical coherence tomography (OCT), and...

Read More

Effect of PDT on the Function of Outer Blood-retinal Barrier

Poster Yun Il Suk Purpose: To evaluate the effect of photodynamic therapy (PDT) with verteporfin on the barrier function of retinal pigment epithelium (RPE) in age related macular degeneration (AMD) patients. Method: This study is retrospective and interventional case series. Twenty-eight eyes of 25 AMD patients with subfoveal or juxtafoveal lesion received PDT between 2007 Jun and 2012 Sep were included. In 28 eyes of the study, 13 eyes...

Read More

Effect of Photodynamic Therapy on the Function of Outer Blood-Retinal Barrier

Purpose: To evaluate the effect of photodynamic therapy (PDT) with verteporfin on the barrier function of retinal pigment epithelium (RPE) in age related macular degeneration (AMD) patients. Method: This study is retrospective and interventional case series. Twenty-eight eyes of 25 AMD patients with subfoveal or juxtafoveal lesion received PDT between June 2007 and September 2012. In 28 eyes of the study, 13 eyes were choroidal...

Read More

Photodynamic Therapy with Verteporfin Combined with Intravitreal Bevacizumab for Choroidal Neovascularization in Angioid Streaks

Levent Karabas, Hande Etus*, Bengu Yucel, Yusuf Çaglar (Kocaeli, Turkey) Advantages: To evaluate safety and efficacy of photodynamic therapy (PDT) with Verteporfin combined with intravitreal bevacizumab for choroidal neovascularization associated with angioid streaks. Methods: Six eyes of six patients treated with PDT with Verteporfin and 0, 05 mg/ml Bevacizumab injections were included. Standardized protocol, visual acuity (VA),...

Read More

Low-fluence Photodynamic Therapy Can Reduce Metamorphopsia in Central Serous Chorioretinopathy Treatment

Sin Woo Bae, Sung Jae Yang, Ju Byung Chae (Seoul, South Korea) Advantages: To compare metamorphopsia changes after two different central serous chorioretinopathy treatments with M-CHART (Inami Co., Tokyo, Japan). Methods: We compared 20 self-resolved eyes with oral medication and 10 eyes with low-fluence (LF) PDT. M-CHART, best corrected visual acuity (BCVA), and optical coherence tomography (OCT) were investigated. Effectiveness /...

Read More

Intravitreal Ranibizumab Combined with Verteporfin Photodynamic Therapy for Treating Polypoidal Choroidal Vasculopathy

Jung Yeul Kim (Daejeon, South Korea) Purpose: To evaluate the efficacy of intravitreal ranibizumab (Lucentis) with verteporfin photodynamic therapy (PDT) for patients with polypoidal choroidal vasculopathy (PCV). Patients and Methods: Seventeen eyes of 17 patients with symptomatic PCV who received three monthly intravitreal ranibizumab injections with PDT were retrospectively reviewed. The follow-up period lasted over 6 months after...

Read More
content top